Vertex's hepatitis C drug Incivek gains Canadian approval

08/22/2011 | Fox Business

Health Canada approved Incivek, Vertex Pharmaceuticals' treatment for genotype 1 hepatitis C in patients with compensated liver disease. Incivek, taken with ribavirin and pegylated interferon, was clinically proven to achieve a higher viral-cure rate than standard therapy.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA